James E. Flynn, 10% Owner: ARS Pharmaceuticals SPRY Sell · Filed 24/11/13

Trade details

Type: Insider sale
Amount: $4,058,920.8
Shares · price: 223,632 sh · $18.15 a share
Held after: 5,274,735 sh
Stock: ARS Pharmaceuticals SPRY
Person: James E. Flynn10% Owner
Trade date: 24/11/11
Filed: 24/11/13
Days to filing: 2 days

Sold 4.1% of holdings

Share of holding sold: 4.1%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/12~24/12/11

James E. Flynn's recent trades

James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$10M
2,000,000 sh
$10M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,012 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,010 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$4.2M
831,978 sh
$4.2M
Filed 03/02
Traded 02/27
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24

James E. Flynn, 10% Owner — sold $4.1M of ARS Pharmaceuticals SPRY · 4.1% of holdings | Whalegun